Alternatively 0 13 0 13 O
, 13 14 13 14 O
patients 15 23 15 23 O
may 24 27 24 27 O
be 28 30 28 30 O
permitted 31 40 31 40 O
to 41 43 41 43 O
enter 44 49 44 49 O
the 50 53 50 53 O
study 54 59 54 59 O
with 60 64 60 64 O
a 65 66 65 66 O
historical 67 77 67 77 O
positive 78 86 78 86 O
bronchoprovocation 87 105 87 105 O
test 106 110 106 110 O
that 111 115 111 115 O
was 116 119 116 119 O
performed 120 129 120 129 O
within 130 136 130 136 O
2 137 138 137 138 B-upper_bound
years 139 144 139 144 I-upper_bound
prior 145 150 145 150 I-upper_bound
to 151 153 151 153 O
Visit 154 159 154 159 O
1 160 161 160 161 O

LAMA 0 4 162 166 B-treatment
use 5 8 167 170 O
within 9 15 171 177 O
3 16 17 178 179 B-upper_bound
months 18 24 180 186 I-upper_bound
prior 25 30 187 192 O
to 31 33 193 195 O
Visit 34 39 196 201 O
101 40 43 202 205 O

Maintenance 0 11 206 217 B-treatment
Immunotherapy 12 25 218 231 I-treatment
( 26 27 232 233 I-treatment
desensitization 27 42 233 248 I-treatment
) 42 43 248 249 I-treatment
for 44 47 250 253 O
allergies 48 57 254 263 O
or 58 60 264 266 O
less 61 65 267 271 O
than 66 70 272 276 O
3 71 72 277 278 O
months 73 79 279 285 O
prior 80 85 286 291 O
to 86 88 292 294 O
Visit 89 94 295 300 O
101 95 98 301 304 O
or 99 101 305 307 O
patients 102 110 308 316 O
on 111 113 317 319 O
Maintenance 114 125 320 331 O
Immunotherapy 126 139 332 345 O
for 140 143 346 349 O
more 144 148 350 354 O
than 149 153 355 359 O
3 154 155 360 361 O
months 156 162 362 368 O
prior 163 168 369 374 O
to 169 171 375 377 O
Visit 172 177 378 383 O
101 178 181 384 387 O
but 182 185 388 391 O
expected 186 194 392 400 O
to 195 197 401 403 O
change 198 204 404 410 O
throughout 205 215 411 421 O
the 216 219 422 425 O
course 220 226 426 432 O
of 227 229 433 435 O
the 230 233 436 439 O
study 234 239 440 445 O

Pre 0 3 446 449 B-clinical_variable
- 3 4 449 450 I-clinical_variable
bronchodilator 4 18 450 464 I-clinical_variable
≥ 19 20 465 466 O
50 21 23 467 469 B-lower_bound
% 23 24 469 470 I-lower_bound
FEV1 25 29 471 475 B-clinical_variable
of 30 32 476 478 O
< 33 34 479 480 O
85 35 37 481 483 B-upper_bound
% 38 39 484 485 I-upper_bound
of 40 42 486 488 O
the 43 46 489 492 O
predicted 47 56 493 502 O
normal 57 63 503 509 O
value 64 69 510 515 O
for 70 73 516 519 O
the 74 77 520 523 O
patient 78 85 524 531 O
after 86 91 532 537 O
withholding 92 103 538 549 O
bronchodilators 104 119 550 565 B-treatment
at 120 122 566 568 O
both 123 127 569 573 O
Visit 128 133 574 579 O
101 134 137 580 583 O
and 138 141 584 587 O
102 142 145 588 591 O
, 145 146 591 592 O
according 147 156 593 602 O
to 157 159 603 605 O
ATS 160 163 606 609 O
/ 163 164 609 610 O
ERS 164 167 610 613 O
criteria 168 176 614 622 O

Repeat 0 6 623 629 O
spirometry 7 17 630 640 B-treatment
may 18 21 641 644 O
be 22 24 645 647 O
allowed 25 32 648 655 O
once 33 37 656 660 O
in 38 40 661 663 O
an 41 43 664 666 O
ad 44 46 667 669 O
- 46 47 669 670 O
hoc 47 50 670 673 O
visit 51 56 674 679 O
if 57 59 680 682 O
the 60 63 683 686 O
spirometry 64 74 687 697 O
did 75 78 698 701 O
not 79 82 702 705 O
qualify 83 90 706 713 O
due 91 94 714 717 O
to 95 97 718 720 O
ATS 98 101 721 724 O
/ 101 102 724 725 O
ERS 102 105 725 728 O
criteria 106 114 729 737 O

Withholding 0 11 738 749 O
period 12 18 750 756 O
of 19 21 757 759 O
bronchodilators 22 37 760 775 B-treatment
prior 38 43 776 781 I-treatment
to 44 46 782 784 I-treatment
spirometry 47 57 785 795 I-treatment
: 57 58 795 796 O
SABA 59 63 797 801 B-treatment
for 64 67 802 805 O
≥ 68 69 806 807 O
6 70 71 808 809 B-lower_bound
hours 72 77 810 815 I-lower_bound
and 78 81 816 819 O
FDC 82 85 820 823 B-treatment
or 86 88 824 826 O
free 89 93 827 831 O
combinations 94 106 832 844 O
of 107 109 845 847 O
ICS 110 113 848 851 B-treatment
/ 113 114 851 852 O
LABA 114 118 852 856 B-treatment
for 119 122 857 860 O
≥ 123 124 861 862 O
48 125 127 863 865 B-lower_bound
hours 128 133 866 871 I-lower_bound
, 133 134 871 872 O
SAMA 135 139 873 877 B-treatment
for 140 143 878 881 O
≥ 144 145 882 883 O
8 146 147 884 885 O
hours 148 153 886 891 O
, 153 154 891 892 O
xanthines 155 164 893 902 B-clinical_variable
> 165 166 903 904 O
= 166 167 904 905 O
07 167 169 905 907 B-lower_bound
days 170 174 908 912 I-lower_bound

Women 0 5 913 918 B-gender
of 6 8 919 921 O
child 9 14 922 927 O
- 14 15 927 928 O
bearing 15 22 928 935 O
potential 23 32 936 945 O
, 32 33 945 946 O
defined 34 41 947 954 O
as 42 44 955 957 O
all 45 48 958 961 O
women 49 54 962 967 B-gender
physiologically 55 70 968 983 O
capable 71 78 984 991 O
of 79 81 992 994 O
becoming 82 90 995 1003 B-pregnancy
pregnant 91 99 1004 1012 I-pregnancy
, 99 100 1012 1013 O
unless 101 107 1014 1020 O
they 108 112 1021 1025 O
are 113 116 1026 1029 O
using 117 122 1030 1035 B-contraception_consent
highly 123 129 1036 1042 I-contraception_consent
effective 130 139 1043 1052 I-contraception_consent
methods 140 147 1053 1060 I-contraception_consent
of 148 150 1061 1063 I-contraception_consent
contraception 151 164 1064 1077 I-contraception_consent
during 165 171 1078 1084 O
dosing 172 178 1085 1091 O
of 179 181 1092 1094 O
study 182 187 1095 1100 B-treatment
treatment 188 197 1101 1110 I-treatment
and 198 201 1111 1114 O
for 202 205 1115 1118 O
30 206 208 1119 1121 B-upper_bound
days 209 213 1122 1126 I-upper_bound
after 214 219 1127 1132 I-upper_bound
stopping 220 228 1133 1141 O
of 229 231 1142 1144 O
study 232 237 1145 1150 O
treatment 238 247 1151 1160 O

demonstrate 0 11 1161 1172 O
an 12 14 1173 1175 O
increase 15 23 1176 1184 O
in 24 26 1185 1187 O
FEV1 27 31 1188 1192 B-clinical_variable
of 32 34 1193 1195 O
12 35 37 1196 1198 O
% 37 38 1198 1199 O
and 39 42 1200 1203 O
200 43 46 1204 1207 O
mL 47 49 1208 1210 O
within 50 56 1211 1217 O
30 57 59 1218 1220 B-upper_bound
minutes 60 67 1221 1228 I-upper_bound
after 68 73 1229 1234 O
administration 74 88 1235 1249 O
of 89 91 1250 1252 O
400 92 95 1253 1256 O
µg 96 98 1257 1259 O
salbutamol/360 99 113 1260 1274 B-treatment
µg 114 116 1275 1277 O
albuterol 117 126 1278 1287 B-treatment
( 127 128 1288 1289 O
or 128 130 1289 1291 O
equivalent 131 141 1292 1302 O
dose 142 146 1303 1307 O
) 146 147 1307 1308 O
at 148 150 1309 1311 O
Visit 151 156 1312 1317 O
101 157 160 1318 1321 O
All 161 164 1322 1325 O
patients 165 173 1326 1334 O
must 174 178 1335 1339 O
perform 179 186 1340 1347 O
a 187 188 1348 1349 O
reversibility 189 202 1350 1363 O
test 203 207 1364 1368 O
at 208 210 1369 1371 O
Visit 211 216 1372 1377 O
101 217 220 1378 1381 O

diagnosis 0 9 1382 1391 O
of 10 12 1392 1394 O
asthma 13 19 1395 1401 B-chronic_disease
, 19 20 1401 1402 O
for 21 24 1403 1406 O
a 25 26 1407 1408 O
period 27 33 1409 1415 O
of 34 36 1416 1418 O
at 37 39 1419 1421 O
least 40 45 1422 1427 O
1 46 47 1428 1429 B-lower_bound
year 48 52 1430 1434 I-lower_bound
prior 53 58 1435 1440 I-lower_bound
to 59 61 1441 1443 O
Visit 62 67 1444 1449 O
1 68 69 1450 1451 O
( 70 71 1452 1453 O
Screening 71 80 1453 1462 O
) 80 81 1462 1463 O

have 0 4 1464 1468 O
ACQ-7 5 10 1469 1474 B-clinical_variable
score 11 16 1475 1480 O
≥ 17 18 1481 1482 O
1.5 19 22 1483 1486 B-lower_bound
at 23 25 1487 1489 O
Visit 26 31 1490 1495 O
101 32 35 1496 1499 O
and 36 39 1500 1503 O
at 40 42 1504 1506 O
Visit 43 48 1507 1512 O
102 49 52 1513 1516 O
( 53 54 1517 1518 O
prior 54 59 1518 1523 B-treatment
to 60 62 1524 1526 I-treatment
double 63 69 1527 1533 I-treatment
- 69 70 1533 1534 I-treatment
blind 70 75 1534 1539 I-treatment
treatment 76 85 1540 1549 I-treatment
) 85 86 1549 1550 O
and 87 90 1551 1554 O
qualify 91 98 1555 1562 O
for 99 102 1563 1566 O
treatment 103 112 1567 1576 B-treatment
with 113 117 1577 1581 I-treatment
medium 118 124 1582 1588 I-treatment
or 125 127 1589 1591 I-treatment
high 128 132 1592 1596 I-treatment
dose 133 137 1597 1601 I-treatment
LABA 138 142 1602 1606 I-treatment
/ 142 143 1606 1607 I-treatment
ICS 143 146 1607 1610 I-treatment

have 0 4 1611 1615 O
a 5 6 1616 1617 O
clinical 7 15 1618 1626 O
condition 16 25 1627 1636 O
which 26 31 1637 1642 O
is 32 34 1643 1645 O
likely 35 41 1646 1652 O
to 42 44 1653 1655 O
be 45 47 1656 1658 O
worsened 48 56 1659 1667 O
by 57 59 1668 1670 O
ICS 60 63 1671 1674 O
administration 64 78 1675 1689 O
( 79 80 1690 1691 O
e.g. 80 84 1691 1695 O
glaucoma 85 93 1696 1704 B-chronic_disease
, 93 94 1704 1705 O
cataract 95 103 1706 1714 B-chronic_disease
and 104 107 1715 1718 O
fragility 108 117 1719 1728 B-chronic_disease
fractures 118 127 1729 1738 I-chronic_disease
) 127 128 1738 1739 O
who 129 132 1740 1743 O
are 133 136 1744 1747 O
according 137 146 1748 1757 O
to 147 149 1758 1760 O
investigator 150 162 1761 1773 O
's 162 164 1773 1775 O
medical 165 172 1776 1783 O
judgment 173 181 1784 1792 O
at 182 184 1793 1795 O
risk 185 189 1796 1800 O
participating 190 203 1801 1814 O
in 204 206 1815 1817 O
the 207 210 1818 1821 O
study 211 216 1822 1827 O
) 216 217 1827 1828 O

have 0 4 1829 1833 O
ever 5 9 1834 1838 O
required 10 18 1839 1847 O
intubation 19 29 1848 1858 B-treatment
for 30 33 1859 1862 O
a 34 35 1863 1864 O
severe 36 42 1865 1871 O
asthma 43 49 1872 1878 B-chronic_disease
attack 50 56 1879 1885 O
/ 56 57 1885 1886 O
exacerbation 57 69 1886 1898 O

have 0 4 1899 1903 O
had 5 8 1904 1907 O
a 9 10 1908 1909 O
respiratory 11 22 1910 1921 B-chronic_disease
tract 23 28 1922 1927 I-chronic_disease
infection 29 38 1928 1937 I-chronic_disease
or 39 41 1938 1940 O
asthma 42 48 1941 1947 B-chronic_disease
worsening 49 58 1948 1957 O
as 59 61 1958 1960 O
determined 62 72 1961 1971 O
by 73 75 1972 1974 O
the 76 79 1975 1978 O
investigator 80 92 1979 1991 O
within 93 99 1992 1998 O
4 100 101 1999 2000 B-upper_bound
weeks 102 107 2001 2006 I-upper_bound
prior 108 113 2007 2012 I-upper_bound
to 114 116 2013 2015 O
Visit 117 122 2016 2021 O
1 123 124 2022 2023 O
( 125 126 2024 2025 O
Screening 126 135 2025 2034 O
) 135 136 2034 2035 O
or 137 139 2036 2038 O
between 140 147 2039 2046 O
Visit 148 153 2047 2052 O
1 154 155 2053 2054 O
and 156 159 2055 2058 O
Visit 160 165 2059 2064 O
102 166 169 2065 2068 O

have 0 4 2069 2073 O
had 5 8 2074 2077 O
an 9 11 2078 2080 O
asthma 12 18 2081 2087 B-chronic_disease
attack 19 25 2088 2094 O
/ 25 26 2094 2095 O
exacerbation 26 38 2095 2107 O
requiring 39 48 2108 2117 O
systemic 49 57 2118 2126 B-treatment
steroids 58 66 2127 2135 I-treatment
or 67 69 2136 2138 O
hospitalization 70 85 2139 2154 B-treatment
or 86 88 2155 2157 O
emergency 89 98 2158 2167 O
room 99 103 2168 2172 O
visit 104 109 2173 2178 O
within 110 116 2179 2185 O
6 117 118 2186 2187 B-upper_bound
weeks 119 124 2188 2193 I-upper_bound
of 125 127 2194 2196 O
Visit 128 133 2197 2202 O
1 134 135 2203 2204 O
( 136 137 2205 2206 O
Screening 137 146 2206 2215 O
) 146 147 2215 2216 O

have 0 4 2217 2221 O
not 5 8 2222 2225 O
achieved 9 17 2226 2234 O
an 18 20 2235 2237 O
acceptable 21 31 2238 2248 O
spirometry 32 42 2249 2259 B-treatment
results 43 50 2260 2267 O
at 51 53 2268 2270 O
Visit 54 59 2271 2276 O
101 60 63 2277 2280 O
in 64 66 2281 2283 O
accordance 67 77 2284 2294 O
with 78 82 2295 2299 O
American 83 91 2300 2308 O
Thoracic 92 100 2309 2317 O
Society 101 108 2318 2325 O
/ 108 109 2325 2326 O
European 109 117 2326 2334 O
Respiratory 118 129 2335 2346 O
Society 130 137 2347 2354 O
( 138 139 2355 2356 O
ATS 139 142 2356 2359 O
/ 142 143 2359 2360 O
ERS 143 146 2360 2363 O
) 146 147 2363 2364 O
criteria 148 156 2365 2373 O
for 157 160 2374 2377 O
acceptability 161 174 2378 2391 O
and 175 178 2392 2395 O
repeatability 179 192 2396 2409 O
( 193 194 2410 2411 O
rescreening 194 205 2411 2422 O
allowed 206 213 2423 2430 O
only 214 218 2431 2435 O
once 219 223 2436 2440 O
) 223 224 2440 2441 O

have 0 4 2442 2446 O
smoked 5 11 2447 2453 O
or 12 14 2454 2456 O
inhaled 15 22 2457 2464 O
tobacco 23 30 2465 2472 O
products 31 39 2473 2481 O
within 40 46 2482 2488 O
the 47 50 2489 2492 O
6 51 52 2493 2494 B-upper_bound
month 53 58 2495 2500 I-upper_bound
period 59 65 2501 2507 O
prior 66 71 2508 2513 O
to 72 74 2514 2516 O
Visit 75 80 2517 2522 O
1 81 82 2523 2524 O
, 82 83 2524 2525 O
or 84 86 2526 2528 O
who 87 90 2529 2532 O
have 91 95 2533 2537 O
a 96 97 2538 2539 O
smoking 98 105 2540 2547 O
history 106 113 2548 2555 O
of 114 116 2556 2558 O
greater 117 124 2559 2566 O
than 125 129 2567 2571 O
10 130 132 2572 2574 B-lower_bound
pack 133 137 2575 2579 I-lower_bound
years 138 143 2580 2585 I-lower_bound

have 0 4 2586 2590 O
used 5 9 2591 2595 O
medium 10 16 2596 2602 O
or 17 19 2603 2605 O
high 20 24 2606 2610 O
dose 25 29 2611 2615 O
ICS 30 33 2616 2619 B-treatment
or 34 36 2620 2622 O
low 37 40 2623 2626 O
dose 41 45 2627 2631 O
of 46 48 2632 2634 O
LABA 49 53 2635 2639 B-treatment
/ 53 54 2639 2640 O
ICS 54 57 2640 2643 O
combinations 58 70 2644 2656 O
for 71 74 2657 2660 O
asthma 75 81 2661 2667 B-chronic_disease
for 82 85 2668 2671 O
at 86 88 2672 2674 O
least 89 94 2675 2680 O
3 95 96 2681 2682 B-lower_bound
months 97 103 2683 2689 I-lower_bound
and 104 107 2690 2693 O
at 108 110 2694 2696 O
stable 111 117 2697 2703 O
doses 118 123 2704 2709 O
for 124 127 2710 2713 O
at 128 130 2714 2716 O
least 131 136 2717 2722 O
1 137 138 2723 2724 B-lower_bound
month 139 144 2725 2730 I-lower_bound
prior 145 150 2731 2736 I-lower_bound
to 151 153 2737 2739 O
Visit 154 159 2740 2745 O
1 160 161 2746 2747 O

history 0 7 2748 2755 O
of 8 10 2756 2758 O
chronic 11 18 2759 2766 B-chronic_disease
lung 19 23 2767 2771 I-chronic_disease
diseases 24 32 2772 2780 I-chronic_disease
other 33 38 2781 2786 O
than 39 43 2787 2791 O
asthma 44 50 2792 2798 B-chronic_disease
, 50 51 2798 2799 O
including 52 61 2800 2809 O
( 62 63 2810 2811 O
but 63 66 2811 2814 O
not 67 70 2815 2818 O
limited 71 78 2819 2826 O
to 79 81 2827 2829 O
) 81 82 2829 2830 O
COPD 83 87 2831 2835 B-chronic_disease
, 87 88 2835 2836 O
sarcoidosis 89 100 2837 2848 B-chronic_disease
, 100 101 2848 2849 O
interstitial 102 114 2850 2862 B-chronic_disease
lung 115 119 2863 2867 I-chronic_disease
disease 120 127 2868 2875 I-chronic_disease
, 127 128 2875 2876 O
cystic 129 135 2877 2883 B-chronic_disease
fibrosis 136 144 2884 2892 I-chronic_disease
, 144 145 2892 2893 O
clinically 146 156 2894 2904 O
significant 157 168 2905 2916 O
bronchiectasis 169 183 2917 2931 B-chronic_disease
and 184 187 2932 2935 O
active 188 194 2936 2942 B-chronic_disease
tuberculosis 195 207 2943 2955 I-chronic_disease

history 0 7 2956 2963 O
of 8 10 2964 2966 O
hypersensitivity 11 27 2967 2983 O
to 28 30 2984 2986 O
lactose 31 38 2987 2994 B-allergy_name
, 38 39 2994 2995 O
any 40 43 2996 2999 O
of 44 46 3000 3002 O
the 47 50 3003 3006 O
study 51 56 3007 3012 O
drugs 57 62 3013 3018 O
or 63 65 3019 3021 O
to 66 68 3022 3024 O
similar 69 76 3025 3032 O
drugs 77 82 3033 3038 O
within 83 89 3039 3045 O
the 90 93 3046 3049 O
class 94 99 3050 3055 O
including 100 109 3056 3065 O
untoward 110 118 3066 3074 O
reactions 119 128 3075 3084 O
to 129 131 3085 3087 O
sympathomimetic 132 147 3088 3103 B-allergy_name
amines 148 154 3104 3110 I-allergy_name
or 155 157 3111 3113 O
inhaled 158 165 3114 3121 B-allergy_name
medication 166 176 3122 3132 I-allergy_name
or 177 179 3133 3135 O
any 180 183 3136 3139 O
component 184 193 3140 3149 O
thereof 194 201 3150 3157 O

may 0 3 3158 3161 O
be 4 6 3162 3164 O
permitted 7 16 3165 3174 O
to 17 19 3175 3177 O
enter 20 25 3178 3183 O
the 26 29 3184 3187 O
study 30 35 3188 3193 O
with 36 40 3194 3198 O
historical 41 51 3199 3209 O
evidence 52 60 3210 3218 O
of 61 63 3219 3221 O
reversibility 64 77 3222 3235 O
that 78 82 3236 3240 O
was 83 86 3241 3244 O
performed 87 96 3245 3254 O
according 97 106 3255 3264 O
to 107 109 3265 3267 O
ATS 110 113 3268 3271 O
/ 113 114 3271 3272 O
ERS 114 117 3272 3275 O
guidelines 118 128 3276 3286 O
within 129 135 3287 3293 O
2 136 137 3294 3295 B-upper_bound
years 138 143 3296 3301 I-upper_bound
prior 144 149 3302 3307 I-upper_bound
to 150 152 3308 3310 O
Visit 153 158 3311 3316 O
1 159 160 3317 3318 O

severe 0 6 3319 3325 O
narcolepsy 7 17 3326 3336 B-chronic_disease
and/or 18 24 3337 3343 O
insomnia 25 33 3344 3352 B-chronic_disease

